BIOASIS TECHNOLOGIES (BIOAF) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 1 4 sessions, September 22, 2025 to September 3, 2026
- Largest daily move
- -50% close of April 13, 2026
Company Description
BIOASIS TECHNOLOGIES (OTC: BIOAF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $288.9K.
This page collects what Stock Titan holds for BIOAF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
BIOASIS TECHNOLOGIES (BIOAF) closed at $0.0001 on September 3, 2026.
BIOAF Metrics & Rankings
Price returns through September 3, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
BIOASIS TECHNOLOGIES has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include acquisition. View all BIOAF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
BIOAF Company Profile & Sector Positioning
BIOASIS TECHNOLOGIES (BIOAF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing BIOAF often look at related companies in the same sector, including ALTAMIRA THERAPEUTICS LTD (CYTOF), RESPIRERX PHARMA INC (RSPI), PANBELA THERAPEUTICS INC (PBLA), VIRACTA THERAPEUTICS INC (VIRX), and TREVENA INC (TRVN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BIOAF's relative position within its industry.